Autoimmune Hyperlipidemia with Inhibitory Monoclonal Antibodies against Low Density Lipoprotein Binding to Fibroblasts in a Case with Multiple Myeloma

Internal Medicine

Volumn 36, Issue 12, 1997, Pages 920-925

  Nozaki, Shuichi ^a   Ito, Yasuo ^b   Nakagawa, Tsutomu ^a   Yamashita, Shizuya ^a   Sasaki, Jun ^c   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c Kitakyushu Tsuyazaki Hospital   (Japan)

Author keywords

Immunoglobulin A (IGA) gammopathy; Lipoprotein; Low density lipoproteins (LDL) receptor; Mechanism; Xanthomatosis

Indexed keywords

IMMUNOGLOBULIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; BINDING COMPETITION; CASE REPORT; FEMALE; FIBROBLAST; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERLIPOPROTEINEMIA; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIPLE MYELOMA; XANTHOMATOSIS;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; BINDING, COMPETITIVE; CHOLESTEROL, LDL; FEMALE; FIBROBLASTS; HUMANS; HYPERGAMMAGLOBULINEMIA; HYPERLIPOPROTEINEMIAS; IMMUNOGLOBULIN A; MIDDLE AGED; MULTIPLE MYELOMA; RECEPTORS, LDL; XANTHOMATOSIS;

EID: 0031303729     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.920     Document Type: Article

References (23)

1. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269: 604, 1977.
2. Utermann G, Vogelberg KH, Steinmetz A, et al. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet 15: 37, 1979.
3. Ghiselli G, Schaefer EJ, Gascon P, Brewer HB Jr. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science 214: 1239, 1981.
4. Lohse P, Brewer HB III, Meng MS, Skarlatos SI, LaRosa JC, Brewer HB Jr. Familial apolipoprotein E deficiency and type III hyperlipoproteinemia due to a premature stop codon in the apolipoprotein E gene. J Lipid Res 33: 1583, 1992.
5. Beaumont JL. Auto-immune hyperlipidemia - An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol 15: 1037, 1970.
6. Corsini A, Roma P, Sommariva D, Fumagalli R, Catapano AL. Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia. J Clin Invest 78: 940, 1986.
7. Kihara S, Matsuzawa Y, Kubo M, et al. Autoimmune hyperchylomicronemia. N Engl J Med 320: 1255, 1989.
8. Yokoyama K, Shinohara N, Wada K. Osseous xanthomatosis and pathologic fracture in a patient with hyperlipidemia. A case report. Clin Orthop 236: 307, 1988.
9. Kodama H, Nakagawa S, Tanioku K. Plane xanthomatosis with antilipoprotein autoantibody. Arch Dermatol 105: 722, 1972.
10. Riesen W, Noseda G, Butler R. Anti-β-lipoprotein activity of human monoclonal immunoglobulins. Vox Sang 22: 420, 1972.
11. Kikgore LL, Patterson BW, Parenti DM, Fisher WR. Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin. J Clin Invest 76: 225, 1985.
12. Sasaki J and Arakawa K. Effect of nifedipine on serum lipids, lipoproteins, and apolipoproteins in patients with essential hypertension. Curr Ther Res 41: 845, 1987.
13. Goto Y, Akanuma Y, Harano Y, et al. Determination by the SRID method of normal values of serum apolipoproteins (A-I, A-II, B, C-II, C-III, and E) in normolipidemic healthy Japanese subjects. J Clin Biochem Nutr 1: 73, 1986.
14. Sakai N, Matsuzawa Y, Hirano K, et al. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler Thromb 11: 71, 1991.
15. 2 using jacalin-agarose chromatography. J Immunol Methods 99: 101, 1987.
16. Ueyama Y, Nozaki S, Yanagi K, et al. Familial hypercholesterolemia-like syndrome with apolipoprotein E-7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases. J Intern Med 235: 169, 1994.
17. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of the cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249: 5153, 1974.
18. Beaumont JL, Beaumont V. Autoimmune hyperlipidemia. Atherosclerosis 26: 405, 1977.
19. Beaumont JL, Buxtorf JC, Lorenzelli-Edouard L, Hyperlipoproteinemias, xanthomatosis, immunoglobulins and autoimmune hyperlipidemia. Atherosclerosis 36: 315, 1980.
20. Feingold KR, Castro GR, Ishikawa Y, Fielding PE, Fielding CJ. Cutaeous xanthoma in association with paraproteinemia in the absence of hyperlipidemia. J Clin Invest 83: 796, 1989.
21. Baudet MF, Dachet C, Beaumont JL. In vitro interaction of LDL, antilipoprotein IgA and human fibroblasts. Biomedicine 29: 217, 1978.
22. Cortese C, Lewis B, Miller NE, et al. Myelomatosis with type III hyperlipoproteinemia - Clinical and metabolic studies. N Engl J Med 307: 79, 1982.
23. Moriyama K, Sasaki J, Takada Y, et al. Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224-Gln) in a hyperlipidemic patient with xanthomatosis. Biochim Biophys Acta 1301: 185, 1996.